Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-20

Clinical Trial Update: Pilot BA Study of New LY03005 vs Pristiq [Phase 1]

View source ↗

Summary

Completion of a Phase 1 pilot bioavailability study comparing LY03005 with Pristiq (desvenlafaxine) in adults with major depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY03005 (LY03005)
  • Pristiq (Desvenlafaxine)

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Major Depression | Phase 1 | Status: COMPLETED